Characteristics and outcomes of surgically staged multiple classifier endometrial cancer-Reference-Cited by-同舟云学术

Characteristics and outcomes of surgically staged multiple classifier endometrial cancer

Published:2024-01 Issue:1 Volume:50 Page:107269
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Bogani Giorgio^ORCID,Betella Ilaria^ORCID,Multinu Francesco^ORCID,Casarin Jvan,GhezzI Fabio^ORCID,Sorbi Flavia^ORCID,VizziellI Giuseppe^ORCID,Petrillo Marco,Cianci Stefano^ORCID,Berretta Roberto^ORCID,PaolinI Biagio,FanfanI Francesco,De Vitis Luigi^ORCID,Scambia Giovanni^ORCID,Mariani Andrea,Colombo Nicoletta,Raspagliesi Francesco

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference19 articles.

1. Cancer statistics, 2023;Siegel;CA A Cancer J Clin,2023

2. Two pathogenetic types of endometrial carcinoma;Bokhman;Gynecol Oncol,1983

3. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma;Concin;Int J Gynecol Cancer,2021

4. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Oaknin;Ann Oncol,2022

5. Integrated genomic characterization of endometrial carcinoma;Nature,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature;Gynecologic Oncology Reports;2024-08

2. Molecular classification of endometrial carcinoma on endometrial biopsy: an early prognostic value to guide personalized treatment;International Journal of Gynecologic Cancer;2024-07-01

3. Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection;International Journal of Molecular Sciences;2024-05-28

4. Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial;International Journal of Gynecologic Cancer;2024-04-23

5. Study Design and Rationale of the ECMC-GART Phase 3 Clinical Study: Early-Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions;2024-04-08